4 years of historical data (2021–2024) · Healthcare · Biotechnology
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
BlackRock Technology and Private Equity Term Trust trades at 47.6x earnings, 86% above its 5-year average of 25.6x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 113%. On a free-cash-flow basis, the stock trades at 3.4x P/FCF, 44% below the 5-year average of 6.1x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $945M | $1.6B | $1.6B | $1.6B | $3.6B |
| Enterprise Value | $945M | $1.6B | $1.6B | $1.6B | $3.6B |
| P/E Ratio → | 47.65 | 43.76 | 7.48 | — | — |
| P/S Ratio | 23.23 | 39.47 | 7.34 | — | — |
| P/B Ratio | 0.98 | 0.90 | 0.78 | 0.81 | 0.91 |
| P/FCF | 3.41 | 5.79 | 7.31 | 5.26 | — |
| P/OCF | 3.41 | 5.79 | 7.31 | 5.26 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
BlackRock Technology and Private Equity Term Trust's enterprise value stands at 26.5x EBITDA, roughly in line with its 5-year average of 26.2x. The Healthcare sector median is 14.4x, placing the stock at a 84% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | 39.47 | 7.34 | — | — |
| EV / EBITDA | 26.48 | 44.99 | 7.48 | — | — |
| EV / EBIT | 26.48 | — | — | — | — |
| EV / FCF | — | 5.79 | 7.31 | 5.26 | — |
Margins and return-on-capital ratios measuring operating efficiency
BlackRock Technology and Private Equity Term Trust earns an operating margin of 87.7%. Operating margins have compressed from 100.2% to 87.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 1.9% is modest. ROIC of 1.4% represents below-average returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 87.7% | 87.7% | 98.1% | 100.2% | 100.1% |
| Net Profit Margin | 87.7% | 87.7% | 98.1% | 100.2% | 100.1% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | 1.9% | 1.9% | 10.4% | -55.1% | -16.1% |
| ROA | 1.8% | 1.8% | 10.3% | -54.5% | -15.9% |
| ROIC | 1.4% | 1.4% | 7.8% | -41.4% | — |
| ROCE | 1.8% | 1.8% | 10.3% | -54.5% | — |
Solvency and debt-coverage ratios — lower is generally safer
Interest coverage of 2313.2x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | 0.00 | -0.00 | -0.00 | -0.00 |
| Net Debt / EBITDA | — | 0.00 | -0.00 | — | — |
| Debt / FCF | — | 0.00 | -0.00 | -0.00 | — |
| Interest Coverage | 2313.25 | 2313.25 | 141140.11 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| Cash Ratio | — | — | — | — | — |
| Asset Turnover | — | 0.02 | 0.10 | -0.80 | -0.16 |
| Inventory Turnover | — | — | — | — | — |
| Days Sales Outstanding | — | 0.60 | 0.56 | -0.92 | -3.65 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
BlackRock Technology and Private Equity Term Trust returns 20.3% to shareholders annually — split between a 10.6% dividend yield and 9.8% buyback yield. The payout ratio exceeds 100% at 517.4%, meaning the company is paying out more than it earns — this level is unsustainable long-term without earnings recovery. The earnings yield of 2.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | 10.6% | 11.5% | 11.1% | 14.4% | 4.5% |
| Payout Ratio | 517.4% | 517.4% | 83.2% | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | 2.1% | 2.3% | 13.4% | — | — |
| FCF Yield | 29.3% | 17.3% | 13.7% | 19.0% | — |
| Buyback Yield | 9.8% | 5.8% | 2.6% | 4.6% | 1.7% |
| Total Shareholder Yield | 20.3% | 17.3% | 13.7% | 19.0% | 6.2% |
| Shares Outstanding | — | $216M | $216M | $240M | $248M |
Compare BTX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $945M | 47.6 | 26.5 | 3.4 | 100.0% | 87.7% | 1.9% | 1.4% | — | |
| $3B | 9.3 | 12.1 | — | 81.5% | 78.9% | 9.4% | 5.9% | 7.1 | |
| $3B | 8.9 | 14.5 | — | 87.2% | 66.7% | 16.2% | 6.6% | 6.3 | |
| $243M | 4.9 | 9.1 | — | 83.5% | 77.9% | 14.1% | 7.2% | 6.2 | |
| $1B | 9.7 | 12.6 | 3.4 | 75.4% | 98.4% | 8.0% | 5.3% | 8.0 | |
| $166B | 25.4 | 20.6 | 35.2 | 49.4% | 37.1% | 14.1% | 9.9% | 1.8 | |
| $3.1T | 30.9 | 19.7 | 43.7 | 68.8% | 45.6% | 33.3% | 24.9% | 0.7 | |
| $4.2T | 38.5 | 29.7 | 42.7 | 46.9% | 32.0% | 171.4% | 67.4% | 0.8 | |
| $5.1T | 43.2 | 38.6 | 53.2 | 71.1% | 60.4% | 101.5% | 81.8% | 0.1 | |
| $4.8T | 36.8 | 32.2 | 65.7 | 59.7% | 32.1% | 35.7% | 25.1% | 0.4 | |
| $1.6T | 26.3 | 15.8 | 33.9 | 82.0% | 41.4% | 30.2% | 27.6% | 0.8 | |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 4 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Golub Capital BDC, Inc..
Start ComparisonQuick answers to the most common questions about buying BTX stock.
BlackRock Technology and Private Equity Term Trust's current P/E ratio is 47.6x. The historical average is 25.6x. This places it at the 100th percentile of its historical range.
BlackRock Technology and Private Equity Term Trust's current EV/EBITDA is 26.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 26.2x.
BlackRock Technology and Private Equity Term Trust's return on equity (ROE) is 1.9%. The historical average is -14.7%.
Based on historical data, BlackRock Technology and Private Equity Term Trust is trading at a P/E of 47.6x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
BlackRock Technology and Private Equity Term Trust's current dividend yield is 10.56% with a payout ratio of 517.4%.
BlackRock Technology and Private Equity Term Trust has 100.0% gross margin and 87.7% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.